​
​

Alimera Sciences (ALIM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Alimera Sciences Revenue Highlights

Latest Revenue (Y)

$80.75M

Latest Revenue (Q)

$23.01M

Main Segment (Y)

United States Segment

Alimera Sciences Revenue by Period

Alimera Sciences Revenue by Year

DateRevenueChange
2023-12-31$80.75M49.19%
2022-12-31$54.13M-8.30%
2021-12-31$59.03M16.15%
2020-12-31$50.82M-5.79%
2019-12-31$53.94M14.85%
2018-12-31$46.97M30.79%
2017-12-31$35.91M4.60%
2016-12-31$34.33M53.01%
2015-12-31$22.44M166.39%
2014-12-31$8.42M349.95%
2013-12-31$1.87M100.00%
2012-12-31-100.00%
2011-12-31-100.00%
2010-12-31-100.00%
2009-12-31-100.00%
2008-12-31-100.00%
2007-12-31-100.00%
2006-12-31--

Alimera Sciences generated $80.75M in revenue during NA 2023, up 49.19% compared to the previous quarter, and up 171.93% compared to the same period a year ago.

Alimera Sciences Revenue by Quarter

DateRevenueChange
2024-03-31$23.01M-12.53%
2023-12-31$26.31M12.59%
2023-09-30$23.36M33.22%
2023-06-30$17.54M29.47%
2023-03-31$13.55M-3.44%
2022-12-31$14.03M3.17%
2022-09-30$13.60M-6.89%
2022-06-30$14.60M22.74%
2022-03-31$11.90M-14.76%
2021-12-31$13.96M14.86%
2021-09-30$12.15M-44.00%
2021-06-30$21.70M93.53%
2021-03-31$11.21M-18.59%
2020-12-31$13.77M10.43%
2020-09-30$12.47M24.26%
2020-06-30$10.04M-30.94%
2020-03-31$14.54M-16.22%
2019-12-31$17.35M35.00%
2019-09-30$12.85M18.38%
2019-06-30$10.86M-15.79%
2019-03-31$12.89M-14.71%
2018-12-31$15.11M35.71%
2018-09-30$11.14M2.02%
2018-06-30$10.92M11.38%
2018-03-31$9.80M7.22%
2017-12-31$9.14M-6.56%
2017-09-30$9.78M-5.63%
2017-06-30$10.37M56.66%
2017-03-31$6.62M-38.02%
2016-12-31$10.68M28.67%
2016-09-30$8.30M-13.17%
2016-06-30$9.56M64.75%
2016-03-31$5.80M-0.38%
2015-12-31$5.82M-15.62%
2015-09-30$6.90M19.48%
2015-06-30$5.78M46.67%
2015-03-31$3.94M126.19%
2014-12-31$1.74M-27.70%
2014-09-30$2.41M9.95%
2014-06-30$2.19M5.09%
2014-03-31$2.08M122.89%
2013-12-31$935.00K23.35%
2013-09-30$758.00K323.46%
2013-06-30$179.00K100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31-100.00%
2009-09-30-100.00%
2009-06-30-100.00%
2009-03-31-100.00%
2008-12-31-100.00%
2008-09-30-100.00%
2008-06-30-100.00%
2008-03-31-100.00%
2007-06-30--

Alimera Sciences generated $23.01M in revenue during Q1 2024, up -12.53% compared to the previous quarter, and up 164.02% compared to the same period a year ago.

Alimera Sciences Revenue Breakdown

Alimera Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
International Segment$24.04M$19.93M$32.29M$26.01M$21.66M
United States Segment$56.71M$34.20M$26.74M$24.81M$32.28M
Other Segments-----

Alimera Sciences's latest annual revenue breakdown by segment (product or service), as of Dec 23: United States Segment (70.23%), and International Segment (29.77%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
International Segment$8.46M$7.12M$5.30M$5.66M$5.96M$4.61M$4.68M$5.66M$4.98M$5.57M$5.24M$15.92M$5.57M$6.41M$5.51M$6.62M$7.47M$7.84M$4.16M$3.54M
United States Segment$14.55M$19.19M$18.06M$11.88M$7.58M$9.42M$8.92M$8.94M$6.92M$8.39M$6.92M$5.79M$5.65M$7.36M$6.96M$3.42M$7.07M$9.51M$8.69M$7.32M
Other Segments--------------------

Alimera Sciences's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: United States Segment (63.24%), and International Segment (36.76%).

Alimera Sciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
ORGOOrganogenesis$433.14M$115.18M
LFCRLifecore Biomedical$128.26M$24.70M
ALIMAlimera Sciences$80.75M$23.01M
DERMJourney Medical$79.18M$14.86M
ADMPAdamis Pharmaceuticals$4.76M$9.06M
SXTCChina SXT Pharmaceuticals$1.97M$939.58K
CYTHCyclo Therapeutics$1.08M$123.10K
LSDILucy Scientific Discovery$7.05K$9.68K
SHPHShuttle Pharmaceuticals--

ALIM Revenue FAQ

What is Alimera Sciences’s yearly revenue?

Alimera Sciences's yearly revenue for 2023 was $80.75M, representing an increase of 49.19% compared to 2022. The company's yearly revenue for 2022 was $54.13M, representing a decrease of -8.30% compared to 2021. ALIM's yearly revenue for 2021 was $59.03M, representing an increase of 16.15% compared to 2020.

What is Alimera Sciences’s quarterly revenue?

Alimera Sciences's quarterly revenue for Q1 2024 was $23.01M, a -12.53% decrease from the previous quarter (Q4 2023), and a 69.87% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $26.31M, a 12.59% increase from the previous quarter (Q3 2023), and a 87.51% increase year-over-year (Q4 2022). ALIM's quarterly revenue for Q3 2023 was $23.36M, a 33.22% increase from the previous quarter (Q2 2023), and a 71.82% increase year-over-year (Q3 2022).

What is Alimera Sciences’s revenue growth rate?

Alimera Sciences's revenue growth rate for the last 3 years (2021-2023) was 36.80%, and for the last 5 years (2019-2023) was 49.70%.

What are Alimera Sciences’s revenue streams?

Alimera Sciences's revenue streams in c 23 are International Segment, and United States Segment. International Segment generated $24.04M in revenue, accounting 29.77% of the company's total revenue, up 20.66% year-over-year. United States Segment generated $56.71M in revenue, accounting 70.23% of the company's total revenue, up 65.81% year-over-year.

What is Alimera Sciences’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Alimera Sciences was United States Segment. This segment made a revenue of $56.71M, representing 70.23% of the company's total revenue.